October 2022
European Heart Journal
REWIND: Does dulaglutide impact a composite outcome reflecting atherosclerosis? A post-hoc analysis
G Ferrannini, L Mellbin, F Kirabo, C Ramasundarahettige, H Gerstein, L Ryden
Read MoreOctober 2022
The Lancet
The polypill – concept to evidence; next step – implementation
Salim Yusuf and Fausto Pinto
Read MoreOctober 2022
Lancet Respiratory Medicine
ACT: Colchicine and aspirin in community patients with COVID-19: an open-label, factorial, randomised, controlled trial
JW Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, L Xu, L Heenan, SI Bangdiwala, WM Tarhuni, M Hassany, A Kontsevaya, W Harper, SK Sharma, P Lopez-Jaramillo, AL Dans, LM Palileo-Villanueva, A Avezum, P Pais, D Xavier, C Felix, A Yusufali, RD Lopes, O Berwanger, Z Ali, S Wasserman, SS Anand, J Bosch, S Choudhri, ME Farkouh, M Loeb, S Yusuf
Read MoreOctober 2022
Lancet Respiratory Medicine
ACT: Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19: an open-label, factorial, randomised, controlled trial
J Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, L Xu, L Heenan, SI Bangdiwala, ML Diaz, R Diaz, A Yusufali, SK Sharma, WM Tarhuni, M Hassany, A Avezum, W Harper, S Wasserman, A Almas, O Drapkina, C Felix, RD Lopes, O Berwanger, P Lopez-Jaramillo, SS Anand, J Bosch, S Choudhri, S Choudhri, ME Farkouh, M Loeb, S Yusuf
Read MoreOctober 2022
Canadian Journal of Public Health
START, FAMILY, RICH LEGACY: The association of maternal sugary beverage consumption during pregnancy and the early years with childhood sugary beverage consumption
J Limbachia, D Desai, N Abdalla, RJ de Souza, K Teo, KM Morrison, Z Punthakee, M Gupta, SA Lear, SS Anand
Read MoreSeptember 2022
JAMA Cardiology
COMPLETE: Complete revascularization vs culprit lesion–only percutaneous coronary intervention for angina-related quality of life in patients with ST-segment elevation myocardial infarction
SR Mehta, J Wang, DA Wood, JA Spertus, DJ Cohen, R Mehran, RF Storey, PG Steg, N Pinilla-Echeverri, T Sheth, KR Bainey, S Bangalore, WJ Cantor, DP Faxon, LJ Feldman, SS Jolly, V Kunadian, S Lavi, J Lopez-Sendon, M Madan, R Moreno, SV Rao, J Rodes-Cabau, G Stankovic, SI Bangdiwala, JA Cairns
Read MoreSeptember 2022
EuroIntervention Journal
EPIC STEMI: Effects of routine early treatment with PCSK-9 inhibitor in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomized, double-blind, sham-controlled trial
SR Mehta, G Pare, EM Lonn, SS Jolly, MK Natarajan, N Pinilla-Echeverri, JD Schwalm, T Sheth, M Sibbald, M Tang, N Valettas, JL Velianou, SF Lee, T Ferdous, S Nauman, H Nguyen, T McCready, MJ McQueen
Read MoreSeptember 2022
JAMA Cardiology
UNIVERSAL: Routine ultrasonography guidance for femoral vascular access for cardiac procedures
SS Jolly, S AlRashidi, MA d'Entremont, O Alansari, B Brochu, L Heenan, E Skuriat, J Tyrwhitt, M Raco, M Tsang, N Valettas, JL Velianou, T Sheth, M Sibbald, SR Mehta, N Pinilla-Echeverri, JD Schwalm, MK Natarajan, A Kelly, E Akl, S Tawadros, M Camargo, W Faidi, J Bauer, R Moxham, J Nkurunziza, G Dutra, J Winter
Read MoreSeptember 2022
European Journal of Heart Failure
REWIND: Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the randomized trial
KRH Branch, GR Dagenais, A Avezum, J Basile, I Conget, WC Cushman, P Jansky, M Lakshmanan, F Lanas, LA Leiter, P Pais, N Pogosova, PJ Raubenheimer, L Ryden, JE Shaw, WHH Sheu, T Temelkova-Kurktschiev, MA Bethel, HC Gerstein, R Chinthanie, JL Probstfield
Read MoreSeptember 2022
The Lancet
PURE: Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis
M Walli-Attaei, A Rosengren, S Rangarajan, Y Breet, S Abdul-Razak, W Al Sharief, KF Alhabib, A Avezum, J Chifamba, R Diaz, R Gupta, B Hu, R Iqbal, R Ismail, R Kelishadi, R Khatib, X Lang, S Li, P Lopez-Jaramillo, V Mohan, A Oguz, LM Palileo-Villanueva, K Poltyn-Zaradna, PR Sreelakshmi, LVM Pinnaka, P Seron, K Teo, ST Verghese, A Wielgosz, K Yeates, R Yusuf, SS Anand, S Yusuf
Read MoreSeptember 2022
The Lancet
PACIFIC-Stroke: Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke – an international, randomised, double-blind, placebo-controlled, phase 2b trial
A Shoamanesh, H Mundi, EE Smith, J Masjuan, I Milanov, T Hirano, A Agafina, B Campbell, V Caso, JL Mas, Dong, P Turcani, H Christensen, JM Ferro, R Veltkamp, R Mikulik, GM De Marchis, T Robinson, R Lemmens, A Stepien, S Greisenegger, R Roine, L Csiba, P Khatri, J Coutinho, AG Lindgren, AM Demchuk, P Colorado, B Kirsch, C Neumann, L Heenan, L Xu, SJ Connolly, RG Hart
Read MoreAugust 2022
The New England Journal of Medicine (NEJM)
INVICTUS: Rivaroxaban in rheumatic heart disease–associated atrial fibrillation
SJ Connolly, G Karthikeyan, M Ntsekhe, A Haileamlak, A El Sayed, A El Ghamrawy, A Damasceno, A Avezum, AML Dans, B Gitura, D Hu, ER Kamanzi, F Maklady, G Fana, JA Gonzalez-Hermosillo, J Musuku, K Kazmi, L Zuhlke, L Gondwe, C Ma, M Paniagua, OS Ogah, OJ Molef-Baikai, P Lwabi, P Chillo, SK Sharma, TTJ Cabral, WM Tarhuni, A Benz, M van Eikels, A Krol, D Pattath, K Balasubramanian, S Rangarajan, C Ramasundarahettige, B Mayosi, S Yusuf
Read MoreAugust 2022
British Journal of Anaesthesia
VISION: Determinants of tobacco smoking abstinence 1 year after major noncardiac surgery: a secondary analysis
S Ofori, M Marcucci, L Mbuagbaw, D Conen, FK Borges, CK Chow, DI Sessler, MTV Chan, GS Hillis, S Pettit, D Heels-Ansdell, PJ Devereaux
Read MoreAugust 2022
European Heart Journal - Quality of Care and Clinical Outcomes
COMPASS: The cost-effectiveness of rivaroxaban with or without aspirin
A Lamy, J Eikelboom, W Tong, F Yuan, SI Bangdiwala, J Bosch, S Connolly, E Lonn, GR Dagenais, KRH Branch, WJ Wang, J Probstfield, G Ertl, S Stork, PG Steg, V Aboyans, I Durand-Zaleski, L Ryden, S Yusuf
Read MoreAugust 2022
Cardiovascular Diabetology
REWIND: A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
HC Gerstein, C Ramasundarahettige, A Avezum, J Basile, I Conget, WC Cushman, GR Dagenais, E Franek, M Lakshmanan, F Lanas, LA Leiter, N Pogosova, J Probstfield, PJ Raubenheimer, M Riddle, J Shawn, WHH Sheu, T Temelkova-Kurktschiev, I Turfanda, D Xavier
Read More